Where Tech Meets Bio
Latest News
A research team at Fujita Health University has developed a precision genome-editing approach to modulate levels of mutant mitochondrial DNA (mtDNA) in patient-derived stem cells, …
Read More
Khondrion Secures €5M to Advance Small Molecule Therapy Toward Phase 3 Trial
Khondrion, a clinical-stage biotech company focused on primary mitochondrial disease (PMD), has secured up to €5M in Innovation Credit from the Netherlands Enterprise Agency, alongside …
Read More
Iktos Brings its Gen-AI Drug Design Platform to AWS Marketplace
Iktos, a company developing AI and robotic technologies for medicinal chemistry and small molecule drug design, has expanded its collaboration with Amazon Web Services (AWS) …
Read More
Latest News
Crown Bioscience Shows 3D Bone Marrow Model to Improve Blood Cancer Drug Testing and Reduce Animal Use
Moderna to Onboard R&D Teams to Benchling Platform for AI-Driven Research Integration
Startup Working with Italian Hospitals Raises €2.2M to Structure Medical Reports into Care Plans
North Bristol NHS Trust Becomes Reference Site for FUJIFILM’s Digital Pathology Platform
Inductive Bio Raises $25M to Scale AI Platform for Predicting Drug Behavior Before Synthesis
Flagship Launches Etiome with $50M to Use AI for Stage-Specific Drug Target Discovery
Latest Insights
by Andreas Dreps, Bea Mann, PhD
Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?
The field of oncology is experiencing a proliferation of cancer therapies. In 2024 alone, the U.S. Food and Drug Administration (FDA) issued more than 60 …
Read More
by BiopharmaTrend
Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific
Novotech CRO has released a global market analysis focused on the clinical trial landscape for Idiopathic Pulmonary Fibrosis (IPF), identifying strategic trends for drug developers …
Read More
How AI, Graphs, and GraphRAG Are Set to Revolutionize Alzheimer's Gene Research and Treatment
by Dominik Tomicevic
Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific
by BiopharmaTrend
Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research
by BiopharmaTrend
AI in Drug Safety: From Concept to Reality, The Industry's Path Forward
by Dr. Karthik Muthusamy
Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development
by Bea Mann, PhD
Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?
by Andreas Dreps, Bea Mann, PhD
The Future of Advanced Therapeutics: Opportunities and Challenges
by Sai Bhamidipati
What CROs Cite as Their Top Clinical Trial Challenges and How They Plan to Overcome Them in 2025
by Megan Deegan
From Our Partners
Sponsored by
Intelligencia AI
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Sponsored by
OPTIC
AI Is Key to Democratizing Drug Discovery
Sponsored by
RECEPTOR.AI
This AI Startup Joins Forces With NVIDIA's BioNeMo to Boost Drug Discovery
Sponsored by
Lantern Pharma
How AI Empowers Biomarker-Driven Clinical Trials
Partner Events

London Biotechnology Show 2025
Event Date: June 18, 2025 - June 19, 2025
Location: United Kingdom (Hall N7 & N8 Bett Global, Excel London, Royal Victoria Dock, 1 Western Gateway, London, UK, England, GB, E16 1XL)
Website: Link
Promo Code: 4CPHAK
Read more ›››

Global Clinical Trials Connect 2025
Promo Code: GCTC10 (valid till 2025-05-28)
Read more ›››

The 12th Aging Research & Drug Discovery Meeting The 11th Aging Research & Drug Discovery Meeting
Event Date: Aug. 25, 2025 - Aug. 29, 2025
Location: Denmark (Ceremonial Hall, University of Copenhagen)
Website: Link
Case Studies
Sponsored by
Roivant Sciences
QUAISAR Computational Platform for Designing Targeted Protein Degraders
Sponsored by
Science Exchange
How Astellas Pharma Achieves R&D Operational Excellence with Science Exchange
Sponsored by
RECEPTOR.AI
Busting the PoseBusters v3: AI Docking Software ArtiDock Beats Industry’s State of the Art in Speed and Accuracy
Sponsored by
Celeris Therapeutics
Application of AI-driven Xanthos Platform for Designing Protein Degraders
Sponsored by
Cyclica
Cyclica's Chemical Probes for DCAF1
Sponsored by
Lantern Pharma
Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®
Sponsored by
Arctoris
Using End-to-End Wet Lab Automation Combined with Machine Learning to Industrialize Drug Discovery
Sponsored by
RECEPTOR.AI
AI Becomes a Drop-in Replacement for Docking
Interviews
On Biotech Engineering and AI: a Conversation with TeselaGen's CEO, Eduardo Abeliuk
Pioneering the Largest Foundation Model to Transform RNA Research: An Interview with Brendan Frey
This South Korean Company is at the Forefront of AI-driven Drug Discovery
A Look at Longevity Industry: Interview with Dr. Eric Leire, CEO of Genflow Biosciences
Most Read
14 Companies Using Quantum Theory To Accelerate Drug Discovery (Including 2 Going Public)
9 Notable AI Companies in Clinical Research to Watch in 2023
12 Notable AI-powered Biotech Companies Founded in 2021
The Increasing Role of CROs in the Pharmaceutical Industry